Detalles de la búsqueda
1.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
J Eur Acad Dermatol Venereol
; 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38284131
2.
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study.
J Am Acad Dermatol
; 90(5): 1031-1034, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199282
3.
Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres.
Clin Exp Dermatol
; 48(12): 1376-1378, 2023 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596961
4.
Patch testing with textile dye mix in Italy: A 2-year multicenter SIDAPA study.
Contact Dermatitis
; 84(4): 265-268, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33063872
5.
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
Dermatol Ther (Heidelb)
; 14(4): 919-932, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38509380
6.
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens.
Ital J Dermatol Venerol
; 159(2): 83-104, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38650492
7.
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
Am J Clin Dermatol
; 25(1): 149-160, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725229
8.
Efficacy and tolerability of a repairing moisturizing cream containing amino-inositole and urea 10% in adults with chronic eczematous dermatitis of the hands.
Ital J Dermatol Venerol
; 158(1): 42-48, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36719406
9.
Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.
Adv Ther
; 40(12): 5366-5382, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801232
10.
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
J Dermatolog Treat
; 33(5): 2565-2570, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35255779
11.
Long-term management of moderate-to-severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA), and the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC).
Ital J Dermatol Venerol
; 157(1): 1-12, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34929995
12.
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment.
Dermatol Ther (Heidelb)
; 12(1): 195-202, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897582
13.
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
J Dermatolog Treat
; 32(2): 164-173, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461356
14.
Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management.
Ital J Dermatol Venerol
; 156(6): 659-664, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33228337
15.
Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata.
Int J Dermatol
; 63(3): 374-375, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197323
16.
Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature.
Int J Dermatol
; 63(3): 399-401, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38200658
17.
Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real-life retrospective study.
Int J Dermatol
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38840319
18.
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
Am J Clin Dermatol
; 25(1): 161, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934365
19.
Eczema herpeticum and herpetic keratitis after the loading dose of dupilumab in a worsening atopic dermatitis: causality?
Int J Dermatol
; 62(12): 1547-1548, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715466
20.
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience.
J Dermatolog Treat
; 34(1): 2268764, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37818648